UK markets close in 4 hours 20 minutes

Abingdon Health Plc (ABDXF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.07000.0000 (0.00%)
At close: 09:32AM EDT

Abingdon Health Plc

York Biotech Campus
Sand Hutton
York YO41 1LZ
United Kingdom
44 19 0440 6050
https://www.abingdonhealth.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees84

Key executives

NameTitlePayExercisedYear born
Mr. Chris Henry Francis YatesCEO & Director316.74kN/A1974
Laura TowseGroup Financial ControllerN/AN/AN/A
Mr. Mark JonesChief Operating OfficerN/AN/AN/A
Ms. Brenda HoganHR DirectorN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays. It also offers AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader; and Salistick, a rapid saliva-based pregnancy test. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it offers regulatory consultancy services for businesses in the diagnostics sector. The company has a strategic collaboration with DeepVerge plc for the development, manufacturing, and commercialization of lateral flow tests; and Vatic Health Limited for the development, manufacturing, and commercialization of infectious disease lateral flow self-tests. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Corporate governance

Abingdon Health Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.